Skip to main content
Clinical Trials/JPRN-UMIN000001611
JPRN-UMIN000001611CompletedPhase 4

The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study- - The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study

Graduate School of Medicine Science, Kumamoto University0 sites50 target enrollmentStarted: January 5, 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients were excluded if patients had been malignant disease, previous upper abdominal surgery, neuropsychiatric disorder, organic brain damage, hepato-renal disorder, cardiopulmonary disorder, symptoms suggesting or were pregnant.

Investigators

Sponsor
Graduate School of Medicine Science, Kumamoto University

Similar Trials

The prevention effect in renal disease... | Clinical Trial